And the results so far has been bitterly disappointing - to say the very least! Small investors worry about cash burn and any subsequent capital raising with its dilutive effects. But I will wait another three months and seek my thrills elsewhere.
Ann: Kazia releases preliminary Cantrixil Phase I data, page-14
Add to My Watchlist
What is My Watchlist?